(Q38362763)

2 September 2017

1 reference

title

Dopamine receptors: classification, properties and drug development (English)

1 reference

2 September 2017

0 references

Beart PM

1

1 reference

2 September 2017

publication date

1 June 1989

1 reference

Clinical and Experimental Pharmacology and Physiology

2 September 2017

published in

1 reference

2 September 2017

volume

16

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

511-515

1 reference

Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high-affinity state of the D2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Positron tomography of a radio-brominated analog of the D1/DA1 antagonist, SCH 23390.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

N-ethylmaleimide inactivates adenylate cyclase-coupled but not presynaptic striatal D-2 receptor systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Dopamine receptors: functions, subtypes and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Multiple receptors for dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Distinct target size of dopamine D-1 and D-2 receptors in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

[125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Two dopamine receptors: biochemistry, physiology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1989.TB01597.X

10.1111/J.1440-1681.1989.TB01597.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference